Download All
Download Selected
Concept Code
Concept Name
Preferred Concept Name
Code System
Value Set
143
Adenovirus types 4 and 7
Adenovirus, type 4 and type 7, live, oral
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
24
anthrax
anthrax vaccine
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
174
cholera, live attenuated
cholera, live attenuated
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
212
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
210
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
225
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
230
COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
301
COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
300
COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
302
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
229
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
COVID-19 Moderna EUA Recipient-Caregiver Fact Sheet - all ages 6 months and older
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
218
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
207
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
311
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
COVID-19 Moderna EUA Recipient-Caregiver Fact Sheet - 6 months through 11 years
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details
219
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation
Vaccines administered (CVX)
VIS Vaccines (IIS)
Details